Atlas Trials

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

Clinical trial NCT03071575 · COMPLETED

Trial details

NCT number
NCT03071575
Sponsor
Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
MeaslesRubellaRubella Syndrome, Congenital
Start date
2017-03-09
Primary completion
2018-03-18
Enrollment
637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.